País: Estados Unidos
Língua: inglês
Origem: NLM (National Library of Medicine)
Salicylic acid (UNII: O414PZ4LPZ) (Salicylic acid - UNII:O414PZ4LPZ)
Coria Laboratories
Salicylic acid
Salicylic acid 60 mg in 1 g
TOPICAL
PRESCRIPTION DRUG
For Dermatologic Use: Salex is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). For Podiatric Use: Salex is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions. Topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. Salex should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. Salex should not be used in children under 2 years of age.
Salex® Cream is available in a 454 g (16 oz.) jar - NDC 13548-010-16 Salex® Lotion is available in a 8 fl. oz. (237 mL) bottle - NDC 13548-011-08 Store at controlled room temperature 20° to 25°C (68° to 77°F). Do not freeze.
unapproved drug other
SALEX- SALICYLIC ACID CREAM SALEX- SALICYLIC ACID LOTION CORIA LABORATORIES _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- SALEX (6% SALICYLIC ACID) CREAM SALEX (6% SALICYLIC ACID) LOTION DESCRIPTION Salex Cream contains 6% salicylic acid USP incorporated into a patented Multivesicular Emulsion (MVE ) vehicle consisting of ammonium lactate, behentrimonium methosulfate, cetearyl alcohol, cetyl alcohol, dimethicone 360, disodium EDTA, glycerin, glyceryl stearate SE, methylparaben, mineral oil, PEG-100 stearate, phenoxyethanol, propylparaben, purified water and trolamine. Salex Lotion contains 6% w/w salicylic acid USP incorporated into a patented Multivesicular Emulsion (MVE) vehicle consisting of ammonium lactate, behentrimonium methosulfate, cetearyl alcohol, cetyl alcohol, dimethicone 360, disodium EDTA, glycerin, glyceryl stearate SE, methylparaben, mineral oil, PEG-100 stearate, propylparaben, purified water and trolamine. Salicylic acid is the 2-hydroxy derivative of benzoic acid having the following structure: This MVE formulation has been shown to provide gradual and prolonged release of the active ingredient into the skin. CLINICAL PHARMACOLOGY Salicylic acid has been shown to produce desquamation of the horny layer of skin while not effecting qualitative or quantitative changes in the structure of the viable epidermis. The mechanism of action has been attributed to a dissolution of intercellular cement substance. In a study of the percutaneous absorption of salicylic acid in a 6% salicylic acid gel in four patients with extensive active psoriasis, Taylor and Halprin showed that the peak serum salicylate levels never exceeded 5 mg/100 mL even though more than 60% of the applied salicylic acid was absorbed. Systemic toxic reactions are usually associated with much higher serum levels (30 to 40 mg/100 mL). Peak serum levels occurred within 5 hours of the topica Leia o documento completo